+
Site Tour

2-year outcomes from the TRILUMINATE Pivotal trial

New TriClip TEER data released - TRILUMINATE Pivotal trial 2-year outcomes, proving TriClip TEER was superior to medical therapy alone at reducing Heart Failure Hospitalization (HFH) at 2-years, while confirming its exceptional safety and effectiveness.

Download

Related Resources

ESC 2021: HF & VHD Guidelines

bRIGHT study

TRENDING TOPICS

The Amulet IDE Trial

Five Year Results fom Amulet™ LAA Randomized Controlled Trial

Amplatzer™ Amulet™ LAA Occluder

Concomitant Catheter Ablation and LAA Occlusion with the Amplatzer™ Amulet™

Epic Mitral – 10-Year Clinical Outcomes

Ten-Year Follow-Up of Mitral Valve Replacement With the Epic Porcine Valve

CONNEXT


TV
RELATED RESOURCES

M-TEER: primary and secondary Mitral Regurgitation - cases, tips and tricks

AV VALVES 2023: TR – Atrial TR

MitraClip - AVVS 1 year 1 minute Mitral - Video

AV VALVES 2023: The Genesis of TEER

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023: Trending Topics – Timing

SAFETY IS A JOURNEY | M. Swaans & G. Leurent

Review the Trends | Mitral focus

AV VALVES 2023: Morphology

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline